Display options
Share it on

Future Virol. 2015;10(8):971-980. doi: 10.2217/fvl.15.62.

H5N1 influenza virulence, pathogenicity and transmissibility: what do we know?.

Future virology

Gabriele Neumann

Affiliations

  1. Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, 575 Science Drive, Madison, WI 53711, USA; Tel.: +1 608 890 2907; ; [email protected].

PMID: 26617665 PMCID: PMC4658657 DOI: 10.2217/fvl.15.62

Abstract

Highly pathogenic influenza viruses of the H5N1 subtype have infected more than 600 people since 1997, resulting in the deaths of approximately 60% of those infected. Multiple studies have established the viral hemagglutinin (HA) surface glycoprotein as the major determinant of H5N1 virulence. HA mediates host-specific virus binding to cells, and mutations that allow efficient binding to viral receptors on mammalian cells are critical (although not sufficient) for H5N1 transmissibility among mammals. The viral polymerase PB2 protein is also a critical virulence determinant, and adaptive mutations in this protein are crucial for efficient H5N1 virus replication in mammals. Additionally, viral proteins (such as NS1 and PB1-F2) with roles in innate immune responses also affect the virulence of highly pathogenic H5N1 viruses.

Keywords: H5N1; HA; NS1; PB1-F2; PB2; influenza; pathogenicity; virulence

References

  1. J Gen Virol. 2015 May;96(Pt 5):975-81 - PubMed
  2. MMWR Morb Mortal Wkly Rep. 2015 Feb 6;64(4):111 - PubMed
  3. PLoS One. 2010 Jun 15;5(6):e11112 - PubMed
  4. J Infect Dis. 2015 May 1;211(9):1399-407 - PubMed
  5. J Virol. 2002 Nov;76(21):11166-71 - PubMed
  6. J Virol. 2007 Apr;81(7):3058-67 - PubMed
  7. Virology. 2011 Apr 25;413(1):139-47 - PubMed
  8. Science. 2013 Jun 21;340(6139):1459-63 - PubMed
  9. Nat Med. 2002 Sep;8(9):950-4 - PubMed
  10. Emerg Infect Dis. 2015 Mar;21(3):511-6 - PubMed
  11. PLoS Pathog. 2013;9(5):e1003392 - PubMed
  12. J Biol Chem. 2011 Mar 4;286(9):7239-47 - PubMed
  13. Annu Rev Med. 2015;66:361-71 - PubMed
  14. FASEB J. 2008 Mar;22(3):733-40 - PubMed
  15. J Virol. 2011 Jan;85(2):652-62 - PubMed
  16. Nature. 2004 Jul 8;430(6996):209-13 - PubMed
  17. PLoS One. 2014 Nov 12;9(11):e112302 - PubMed
  18. PLoS Pathog. 2008 Feb 8;4(2):e11 - PubMed
  19. J Virol. 2014 Aug;88(16):8843-52 - PubMed
  20. Virol J. 2013 Jul 25;10 :243 - PubMed
  21. PLoS One. 2011;6(5):e19511 - PubMed
  22. Cell Mol Immunol. 2010 May;7(3):235-42 - PubMed
  23. Nat Med. 2007 Feb;13(2):147-9 - PubMed
  24. J Virol. 2008 Feb;82(3):1146-54 - PubMed
  25. Virus Genes. 2008 Jun;36(3):471-8 - PubMed
  26. Nature. 2005 Jul 14;436(7048):191-2 - PubMed
  27. J Virol. 1993 Apr;67(4):1761-4 - PubMed
  28. Virus Res. 2013 Dec 5;178(1):63-77 - PubMed
  29. J Virol. 2007 Aug;81(15):8112-21 - PubMed
  30. PLoS Pathog. 2010 Sep 16;6(9):e1001106 - PubMed
  31. J Virol. 2010 Feb;84(4):2122-33 - PubMed
  32. Science. 2005 Aug 19;309(5738):1206 - PubMed
  33. J Virol. 2010 Oct;84(19):10051-62 - PubMed
  34. J Virol. 2010 May;84(9):4395-406 - PubMed
  35. J Virol. 2011 Oct;85(20):10639-48 - PubMed
  36. Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4381-6 - PubMed
  37. PLoS Pathog. 2007 Oct 5;3(10):1374-9 - PubMed
  38. Infect Genet Evol. 2015 Apr;31:64-7 - PubMed
  39. Virology. 1998 Dec 20;252(2):324-30 - PubMed
  40. PLoS Pathog. 2010 Aug 05;6(8):e1001034 - PubMed
  41. Science. 2012 Jun 22;336(6088):1534-41 - PubMed
  42. PLoS Pathog. 2005 Sep;1(1):e4 - PubMed
  43. J Virol. 2006 Jun;80(12):5976-83 - PubMed
  44. J Virol. 2013 May;87(9):4861-71 - PubMed
  45. Cell Microbiol. 2011 Dec;13(12 ):1907-19 - PubMed
  46. Mol Cell. 1998 Jun;1(7):991-1000 - PubMed
  47. Trends Microbiol. 2012 Jan;20(1):11-20 - PubMed
  48. Cell Microbiol. 2008 May;10(5):1140-52 - PubMed
  49. Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2845-50 - PubMed
  50. Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):13093-8 - PubMed
  51. Biol Chem. 2012 May;393(6):525-34 - PubMed
  52. J Gen Virol. 2010 Aug;91(Pt 8):1984-95 - PubMed
  53. Lancet. 1998 Feb 14;351(9101):472-7 - PubMed
  54. J Virol. 2010 Nov;84(21):11164-74 - PubMed
  55. Nature. 2006 Mar 23;440(7083):435-6 - PubMed
  56. PLoS Pathog. 2007 Oct 5;3(10):1414-21 - PubMed
  57. J Immunol. 2010 Oct 15;185(8):4812-23 - PubMed
  58. Science. 2006 Mar 17;311(5767):1576-80 - PubMed
  59. PLoS Pathog. 2011 Aug;7(8):e1002186 - PubMed
  60. J Virol. 2012 Aug;86(16):8359-66 - PubMed
  61. Cell. 2014 Apr 10;157(2):329-39 - PubMed
  62. J Virol. 2004 Jun;78(12):6304-12 - PubMed
  63. Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8950-5 - PubMed
  64. J Virol. 2010 May;84(9):4442-50 - PubMed
  65. PLoS Pathog. 2011 Aug;7(8):e1002202 - PubMed
  66. Science. 2001 Sep 7;293(5536):1840-2 - PubMed
  67. Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18590-5 - PubMed
  68. Vaccine. 1998 May-Jun;16(9-10):977-8 - PubMed
  69. Virology. 2012 Jan 5;422(1):105-13 - PubMed
  70. Biol Chem. 2011 Dec;392(12):1135-44 - PubMed
  71. J Virol. 2005 Sep;79(18):12058-64 - PubMed
  72. J Infect Dis. 2011 Mar 15;203(6):880-8 - PubMed
  73. Virol J. 2011 Jan 12;8:13 - PubMed
  74. Science. 1998 Jan 16;279(5349):393-6 - PubMed
  75. Nature. 2012 May 02;486(7403):420-8 - PubMed
  76. Cell Host Microbe. 2007 Oct 11;2(4):240-9 - PubMed
  77. Nat Med. 2001 Dec;7(12):1306-12 - PubMed
  78. J Virol. 2010 Oct;84(20):10708-18 - PubMed
  79. Nat Commun. 2014 Oct 07;5:5021 - PubMed
  80. PLoS One. 2012;7(8):e43948 - PubMed
  81. J Virol. 2014 May;88(9):4828-38 - PubMed
  82. PLoS Pathog. 2011 Jun;7(6):e1002067 - PubMed
  83. J Virol. 2011 Jul;85(14):7048-58 - PubMed
  84. Proc Natl Acad Sci U S A. 2009 Dec 15;106(50):21312-6 - PubMed
  85. Curr Top Microbiol Immunol. 2014;385:221-42 - PubMed
  86. PLoS Pathog. 2010 Jul 22;6(7):e1001014 - PubMed
  87. Acta Histochem Suppl. 1990;40:35-8 - PubMed

Publication Types

Grant support